Feb 10 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 167.05 149.66 225.34
(+11.6 pct) (-14.0 pct) (+11.3 pct)
Operating 5.47 2.43 5.25
(+125.3 pct) (-47.0 pct) (+89.8 pct)
Recurring 7.37 3.09 5.75
(+138.2 pct) (-38.3 pct) (+32.4 pct)
Net 4.60 888 mln 2.49
(+417.2 pct) (-46.3 pct) (+503.1 pct)
EPS 103.97 yen 20.10 yen 56.25 yen
EPS Diluted 103.59 yen 20.04 yen
Ann Div 30.00 yen 30.00 yen
-Q2 div 15.00 yen 15.00 yen
-Q4 div 15.00 yen 15.00 yen
NOTE - Xebio Holdings Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T